Advancing Precision Medicine Symposium 2024

Thank you for joining us!

Mark your calendars for the next Advancing Precision Medicine Symposium on

Tuesday October 7th 2025

“The Leading Edge of Precision Medicine”

Agenda

Breakfast and Registration (8:00 am – 9:00 am)
Welcome Remarks (9:00 am – 9:30 am)
Keynote: Gail Jarvik (9:30 am – 10:30 am)
Poster Session (10:30 am – 11:15 am)
Concurrent Scientific Talks (11:15 am – 12:30 pm)
Lunch and Networking (12:30 pm – 1:15 pm)
Keynote: Daniel Geschwind (1:15 pm – 2:15)
Break (2:15 pm – 2:30 pm)
Concurrent Education Sessions (2:30 pm – 3:45 pm)
Reception & Posters (3:45 pm – 6:00 pm)

Co-Chairs

Gaelen Hess & Jessica Lang

Scientific Committee

John Svaren
Irene Ong
Corinne Engelman
Melissa Skala
Jane Churpek

Keynote Speakers

Gail Jarvik

Dr. Jarvik is the Arno G. Motulsky Endowed Chair in Medicine, Joint Professor of Medicine and Genome Sciences, and Head of the Division of Medical Genetics (only the third since the founding of the division in 1957), an Adjunct Professor of Epidemiology at the University of Washington Medical Center (UWMC) and an Affiliate Member of the Fred Hutchinson Cancer Research Center. She is a Pew Scholar in the Biomedical Sciences and has been made a Lifetime National Associate of the National Academies. Dr. Jarvik is interested in the genetic basis of complexly inherited disease and has a long-standing interest in biomedical ethics. In addition to many collaborations, including GWAS studies of multiple phenotypes and exomic analyses of Mendelian disorders, Dr. Jarvik’s ongoing research focuses on these major areas: complex disease discovery and genomic medicine implementation.

Daniel Geschwind

Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Neurology, Psychiatry and Human Genetics at UCLA. In his capacity as Senior Associate Dean and Associate Vice Chancellor of Precision Health, he leads the Institute for Precision Health (IPH) at UCLA. In his laboratory, his group has pioneered the application of systems biology methods in neurologic and psychiatric disease, with a focus on autism spectrum disorders (ASD) and neurodegenerative conditions. His laboratory has made major contributions to identifying genetic causes of autism spectrum disorder, defining the molecular pathology of autism and allied psychiatric disorders, and has worked to increase diversity in autism research. His work in dementia is focused on the mechanisms of tauopathies, where his laboratory is developing novel therapeutic approaches. He sits on editorial boards of Cell, Science and Neuron, and is among the highest cited neurologists in the world. He has received several awards for his laboratory’s work including the American Neurological Association (ANA) Derek Denny-Brown Neurological Scholar Award, most recently the Society of Biological Psychiatry Gold Medal Award and the American Academy of Neurology’s 2022 Cotzias Lecture and Award. He is the 2022 National Academy of Medicine recipient of the Rhoda and Bernard Sarnat International Prize in Mental Health. He is an elected Member of the American Association of Physicians and the National Academy of Medicine.